Phase 2 Readout~quarter
Phase 2 Readout: abi-6250
- Drug
- abi-6250
- Indication
- chronic hepatitis delta virus
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.